Literature DB >> 16760396

Inhibition of dengue virus replication by mycophenolic acid and ribavirin.

Ratree Takhampunya1, Sukathida Ubol, Huo-Shu Houng, Craig E Cameron, Radhakrishnan Padmanabhan.   

Abstract

Dengue viruses (DEN), mosquito-borne members of the family Flaviviridae, are human pathogens of global significance. The effects of mycophenolic acid (MPA) and ribavirin (RBV) on DEN replication in monkey kidney (LLC-MK2) cells were examined. MPA (IC(50)=0.4+/-0.3 microM) and RBV (IC(50)=50.9+/-18 microM) inhibited DEN2 replication. Quantitative real-time RT-PCR of viral RNA and plaque assays of virions from DEN2-infected and MPA (10 microM)- and RBV (> or =200 microM)-treated cells showed a fivefold increase in defective viral RNA production by cells treated with each drug. Moreover, a dramatic reduction of intracellular viral replicase activity was seen by in vitro replicase assays. Guanosine reversed the inhibition of these compounds, suggesting that one mode of antiviral action of MPA and RBV is by inhibition of inosine monophosphate dehydrogenase and thereby depletion of the intracellular GTP pool. In addition, RBV may act by competing with guanine-nucleotide precursors in viral RNA translation, replication and 5' capping.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760396     DOI: 10.1099/vir.0.81655-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  49 in total

1.  Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells.

Authors:  Li Ye; Jieliang Li; Ting Zhang; Xu Wang; Yizhong Wang; Yu Zhou; Jinping Liu; Hemant K Parekh; Wenzhe Ho
Journal:  Virus Res       Date:  2012-06-21       Impact factor: 3.303

Review 2.  Flavivirus RNA synthesis in vitro.

Authors:  Radhakrishnan Padmanabhan; Ratree Takhampunya; Tadahisa Teramoto; Kyung H Choi
Journal:  Methods       Date:  2015-08-10       Impact factor: 3.608

3.  High-content assay to identify inhibitors of dengue virus infection.

Authors:  David Shum; Jessica L Smith; Alec J Hirsch; Bhavneet Bhinder; Constantin Radu; David A Stein; Jay A Nelson; Klaus Früh; Hakim Djaballah
Journal:  Assay Drug Dev Technol       Date:  2010-10       Impact factor: 1.738

Review 4.  Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity.

Authors:  M L Ritter; L Pirofski
Journal:  Transpl Infect Dis       Date:  2009-05-26       Impact factor: 2.228

Review 5.  Molecular targets for flavivirus drug discovery.

Authors:  Aruna Sampath; R Padmanabhan
Journal:  Antiviral Res       Date:  2008-09-15       Impact factor: 5.970

6.  Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.

Authors:  Yijin Wang; Wenshi Wang; Lei Xu; Xinying Zhou; Ehsan Shokrollahi; Krzysztof Felczak; Luc J W van der Laan; Krzysztof W Pankiewicz; Dave Sprengers; Nicolaas J H Raat; Herold J Metselaar; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

7.  Homogeneity of Powassan virus populations in naturally infected Ixodes scapularis.

Authors:  Doug E Brackney; Ivy K Brown; Robert A Nofchissey; Kelly A Fitzpatrick; Gregory D Ebel
Journal:  Virology       Date:  2010-07-05       Impact factor: 3.616

8.  Identification of novel small-molecule inhibitors of West Nile virus infection.

Authors:  Amine O Noueiry; Paul D Olivo; Urszula Slomczynska; Yi Zhou; Ben Buscher; Brian Geiss; Michael Engle; Robert M Roth; Kyung Min Chung; Melanie Samuel; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  The development, optimization and validation of an assay for high throughput antiviral drug screening against Dengue virus.

Authors:  Pulin Che; Lihua Wang; Qianjun Li
Journal:  Int J Clin Exp Med       Date:  2009-12-08

10.  Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.

Authors:  Hong-Tao Xu; Susan P Colby-Germinario; Said Hassounah; Peter K Quashie; Yingshan Han; Maureen Oliveira; Brent R Stranix; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.